MONOPAR THERAPEUTICS INC shareholders Q3 2023

MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 14 filers reported holding MONOPAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

MONOPAR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Windsor Advisory Group, LLC 89,974$55,7750.13%
Rappaport Reiches Capital Management, LLC 10,695$6,6300.00%
Tower Research Capital LLC (TRC) 3,727$2,3110.00%
JPMORGAN CHASE & CO 4$20.00%
VANGUARD GROUP INC 87,596$54,3010.00%
UBS Group AG 72$450.00%
WELLS FARGO & COMPANY/MN 33$200.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 41,199$23,4830.00%
MILLENNIUM MANAGEMENT LLC 19,008$10,8350.00%
MORGAN STANLEY 800$4960.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,461$5,9630.00%
TWO SIGMA SECURITIES, LLC 24,663$15,2890.00%
HRT FINANCIAL LP 13,078$70.00%
External links

This page lists MONOPAR THERAPEUTICS INC's shareholders in Q3 2023. To view MONOPAR THERAPEUTICS INC's shareholder history, click here.